BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22046792)

  • 21. Ovarian mucinous cystadenoma coexisting with benign Brenner tumor: MR imaging findings.
    Kato H; Kanematsu M; Furui T; Morishige K; Hirose Y
    Abdom Imaging; 2013 Apr; 38(2):412-6. PubMed ID: 22476372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Borderline Brenner Tumor of the Ovary Coexisting With an Ovarian Mucinous Cystadenoma With Focal Atypical Epithelial Proliferation: A Rare Case With Review of the Literature.
    Salibay CJ; Zanfagnin V; Miller H; Walia S; Brunette LL; Wang T
    Int J Surg Pathol; 2021 Oct; 29(7):788-793. PubMed ID: 33635096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
    Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
    Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Borderline ovarian tumors. Current data].
    Duvillard P
    Ann Pathol; 1996 Nov; 16(5):396-405. PubMed ID: 9004728
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of topoisomerase III alpha in epithelial ovarian tumors of different types and relation between the expression of topoisomerase III alpha and the clinical pathology of tumor].
    Zhang WY; Pan Y; Zhu LR; Zhang JZ; Zhang M; Feng K; Zhou L; Yu L; Zhang XM; Ng SW
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2988-91. PubMed ID: 16324386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathology of and controversial aspects of ovarian borderline tumours.
    McCluggage WG
    Curr Opin Oncol; 2010 Sep; 22(5):462-72. PubMed ID: 20531187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brenner tumour arising from the wall of a mucinous cystadenoma.
    Ohara N; Murao S
    J Obstet Gynaecol; 2002 Sep; 22(5):566. PubMed ID: 12521442
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
    Giurgea NL; Pitrop M; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huge primary retroperitoneal mucinous cystadenoma of borderline malignancy mimicking an ovarian mass: case report and review.
    Bifulco G; Mandato VD; Giampaolino P; Nappi C; De Cecio R; Insabato L; Tarsitano F; Mignogna C
    Anticancer Res; 2008; 28(4C):2309-15. PubMed ID: 18751411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent endocervical-like mucinous borderline tumor (ELMBT) arising in a case of long-standing endometriosis--a case report.
    Srinivasan R; Gupta N; Gupta I
    Indian J Pathol Microbiol; 2006 Apr; 49(2):277-8. PubMed ID: 16933740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin expression in ovarian cancer.
    Liguang Z; Peishu L; Hongluan M; Hong J; Rong W; Wachtel MS; Frezza EE
    Exp Oncol; 2007 Jun; 29(2):121-5. PubMed ID: 17704744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.